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(GIMAPs) GTPase of the immunity associated protein family are a novel protein family of putative small GTPases. GIMAPs
are mainly expressed in the cells of the immune system and have been associated with immunological functions, such as
thymocyte development, apoptosis of peripheral lymphocytes and T helper cell diﬀerentiation. GIMAPs have also been linked
to immunological diseases, such as T cell lymphopenia, leukemia and autoimmune diseases. In this review we examine the role of
GIMAP proteins in T-lymphocyte biology.
1.GTPase ofthe Immunity-Associated
ProteinFamily(GIMAP)
GTPase of the immunity-associated protein family
(GIMAPs), also termed immune-associated nucleotide-
binding proteins (IANs), are a relatively recently described,
uncharacterized protein family of putative small GTPases
conserved among vertebrates and higher plants [1–4].
The original publications describing the diﬀerent human,
mouse, and rat GIMAP family members used a variety of
diﬀerentnamesforthegenesgeneratingconfusion.Thus,the
GIMAP nomenclature followed also in this minireview was
introduced by the HUGO Gene Nomenclature Committee
and includes the human, mouse, and rat orthologs [5]
(Table 1).
Small GTP (guanosine triphosphate) binding proteins,
also known as small GTPases, Ras-like GTPases, or Ras
superfamily of GTP binding proteins, regulate key cellu-
lar functions in virtually all living organisms. They are
involved in signal transduction events and regulation of gene
expression in almost all cell types, including the cells of
the immune system [26–28]. The Ras superfamily can be
subclassiﬁed into Ras, Rho, Rab, and Arf families, and the
closely related Gα family of the heterotrimeric G proteins,
which sometimes are excluded from the RAS superfamily
[29].TheRasproteinsinducesignalingpathwaysthatinclude
a variety of second messengers, such as calcium and cAMP.
The Ras superfamily proteins play key roles in a variety
of cellular functions in the immune system, such as cell
migration [30], T-cell anergy [31, 32], antigen presentation,
[33] and radical formation [34].
The GIMAP family members have unique primary
structures and, thus, they deﬁne a new family of G proteins
distinct from the Ras superfamily and the heterotrimeric
G proteins [1]. The expression of GIMAPsi nv e r t e b r a t e s
has been shown to be highest in the cells of the immune
system, although a more ubiquitous expression has also
been suggested. Several studies have associated GIMAPs with
immunological functions, such as thymocyte development
andapoptosisregulationinlymphocytes.Thesearediscussed
in what follows.
2.GenomicOrganizationofGIMAP Genes
All vertebrate species examined so far have GIMAP genes in
tight clusters in their genome [3, 4, 12]. The seven functional
human GIMAP genes and one pseudogene are clustered on
chromosome7q36.1[3]andthereareeightfunctionalmouse
Gimaps clustered on chromosome 6 and seven functional
genesinratchromosome4[13,25].Theongoingsequencing2 Journal of Signal Transduction
Table 1: Nomenclature of the human, mouse, and rat GIMAP genes and gene expression sites.
Gene Synonyms, human Synonyms, mouse Synonyms, rat Size kDa
(human) Expression Reference
GIMAP1 GIMAP1, IMAP1, HIMAP1,
IMAP38, hIan2
Gimap1, imap,
IAP38, Imap38,
mIan2
Gimap1, rIan2,
Imap38,
MGC156493
34.4
thymocytes, spleen,
lymphocytes (T, B, NK),
macrophages, cell lines (LTR6,
C1498, TK-1, A20, P815)
[6–10]
GIMAP2
GIMAP2, IMAP2, HIMAP2,
hIan12, MGC24275,
DKFZp586D0824
no mouse ortholog no rat ortholog 38.0 spleen, lymph nodes, PBL,
thymus [3]
GIMAP3 GIMAP3P (pseudogene)
Gimap3, mIan4,
Gimap5,
2010110D23Rik
not annotated spleen, cell lines expressing
BCR/ABL [11]
GIMAP4
GIMAP4, IAN1, IMAP4,
hIan1, HIMAP4, MSTP062,
FLJ11110
Gimap4, mIan1,
IMAP4, mIAN1,
AU019574,
MGC11734,
E430007K16Rik
Gimap4, rIan1 37.5 splenocytes, lymphocytes (T
and B), thymocytes [12–16]
GIMAP5
GIMAP5, IAN4, IAN5,
IMAP3, hIan5, HIMAP3,
IAN4L1, FLJ11296, Irod
Gimap5, mIan5,
D630024P16,
E230026N22Rik
Gimap5, IAN4,
rIan5, Ian4l1 34.8
wide tissue distribution
outside the central nervous
system
[17–24]
GIMAP6 GIMAP6, hIan6, hIAN2,
FLJ22690, DKFZp686A01175
Gimap6, mIan6,
FLJ00102;
MGC41522,
mFLJ00102,
4833419H03Rik
Gimap6, rIan6,
MGC108948 32.9 spleen, lymph nodes, lungs,
placenta [3]
GIMAP7 GIMAP7, IAN7, hIan7,
MGC27027
Gimap7, mIan7,
mIan3, MGC41480
Gimap7, rIan3,
MGC108919 34.5 spleen, thymus, lymph nodes,
PBL [3]
GIMAP8
GIMAP8, IANT, hIAN6,
MGC129545, DKFZp667I133,
hIan11/10/9, hIan4/3/6
Gimap8, IAN9,
Gm457, IMAP8,
mIan9
mIan11/10/9
Gimap8,
rIan11/10/9,
IanT,
MGC116406
74.9 thymus, spleen [3, 12, 13,
25]
GIMAP9 orthologous to human
GIMAP7
Gimap9,
BB145400,
A630002K24,
mIan3 mIan7
Gimap9,
MGC124918,
rIan3
thymus, lymph nodes [3, 13, 20]
aGIMAP10P no human ortholog
Gimap10-ps
(pseudogene),
mIan8
no rat ortholog [3]
project of the genome of Danio rerio (zebraﬁsh) has revealed
the existence of Gimap orthologs also in a lower vertebrate.
The genomic organization of human, mouse and rat GIMAP
genes is depicted in Figure 1.
Homolog searches in available corn, soybean, and
tobacco genomes by Liu et al. [4] came up with one
to two homologs of GIMAP/IAN g e n e si ne a c hg e n o m e .
However, searches within the well-characterized genomes of
the unicellular organisms Saccharomyces cerevisiae (Baker’s
yeast) and Schizosaccharomyces pombe (ﬁssion yeast), or
invertebrates, such as Caenorhabditis elegans (free-living
roundworm) and Drosophila melanogaster (fruit ﬂy) did not
reveal any homologs of the GIMAP gene family [4]. Thus,
GIMAP genes exist only in vertebrates and angiosperm (i.e.,
ﬂowering) plants and the yet poorly characterized cellular
functions of the GIMAP proteins are speciﬁc for vertebrates
and higher plants.
GIMAP/IANproteinsemergedbeforeplantsandanimals
split into their own evolutionary paths [4]. Phylogenetic
analyses of both protein and genomic sequences [3, 4]
showed that human and mouse GIMAPs 1, 4, 5, 6, 7, and
8 form highly orthologous pairs, and, thus, suggest that a
gene duplication event in a common ancestor of rodents and
primates gave rise to these genes. The phylogenetic analyses
by Liu et al. [4] place the Arabidopsis and rice IANs to a clade
distinct from the mouse and human GIMAP proteins, thus
indicating that the gene duplication events have taken place
after the divergence of vertebrates and plants.
3. Featuresof GIMAPProteins
Human GIMAP proteins are relatively small proteins with
one GTPase domain. Their molecular sizes range fromJournal of Signal Transduction 3
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Figure 1: GIMAP gene clusters in human, mouse, and rat chromosomes. The GIMAP genes are clustered in human chromosome 7q36.1,
mouse chromosome 6, and rat chromosome 4.
34kDa to 38kDa. GIMAP8 makes an exception by having
three GTPase domains, which is extremely unusual not only
for GIMAPs, but for small GTPases in general, too. Thus,
its molecular size is 74.9kDa, making it by far the largest
GIMAP protein.
The GTPase domain with the ﬁve motifs G1-G5 char-
acteristic for all small GTPases is included in the AIG1
domain, named after the prototype gene AIG1 found in
Arabidopsis thaliana (avrRpt2-induced gene) [35]. The AIG1
domain is found in all GIMAP and IAN proteins and
besides the GTPase motifs, it contains a conserved box,
which is characteristic for all AIG1 domain GTPases [3]. All
human GIMAPs also contain putative coiled coil domains
which suggest protein-protein interactions. Some GIMAPs,
namely, GIMAP1, 2, 4, and 5, contain putative transmem-
brane domains in their COOH-terminal ends and GIMAP7,
GIMAP6, GIMAP1, and GIMAP2 have basic amino acids
in their NH2- or COOH-terminus with weak similarity
to endoplasmic reticulum- (ER)-localization signals [3].
However, localization studies found GIMAP4 mainly in
cytosol [12, 14] but also in ER and Golgi [3] and in
membrane fraction of fractionated CD4+ T-lymphocytes
[36]. GIMAP1 has been reported to localize in ER [6]a n d
GIMAP7 in ER and Golgi [3].
HumanGIMAP4wasshowntobeabletobindguanosine
nucleotides GTP and GDP but not GMP or other nucleotide
triphosphates ATP, CTP or TTP [15]. GIMAP4 showed also
intrinsic GTPase activity [15]. Besides the GTP, binding
domain, GIMAP4 protein has other interesting motifs. It
has a carboxy-terminal IQ domain, which is known to
bind calmodulin, a second messenger molecule involved
in, among other cellular processes, TCR signaling, and
activation of NFAT in T-cells [14, 37]. The IQ motif
usually consists of ∼23 residues and contains the consensus
sequence hydrophobQxxxRxxxxRxxxR/K, where hydrophob
is a hydrophobic residue [14]. This motif was proven
to be functional in murine GIMAP4 and, furthermore,
seems to be absent from other GIMAP protein family
members [14]. Also the putative phosphoylation sites of
murine GIMAP4 were shown to be functional, since mouse
GIMAP4 was phosphrorylated rapidly after 10 minutes of
PMA/ionomycin stimulation in primary splenocytes [14].
The phosphorylation was mediated by PKC since it was
inhibited by a PKC inhibitor, Rottlerin. Interestingly, this
phosphorylation was diminished completely after 40–60
minutes of stimulation. Four of the six putative phos-
phorylation sites of mouse GIMAP4 are also found in
human GIMAP4. Thus, GIMAP4 is a lymphocytic signaling
molecule.
4. GIMAPsinT-lymphocyte Development
andFunction
4.1.GIMAPsinThymocyteDevelopment. Cellsurfaceexpres-
sion of leukocyte markers CD4 and CD8 deﬁnes the
stages of T-cell development in the thymus. During the
development process, thymocytes mature from CD4
−CD8
−
double negative (DN) cells into CD4+CD8+ double positive
(DP) cells and ﬁnally into single positive (SP) CD4+ or4 Journal of Signal Transduction
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Figure 2: Thymocyte development. T-cells are developed in the thymus. The development can be deﬁned by cell surface expression of CD4
and CD8. During the process, the thymosytes mature from CD4
−CD8
− double negative (DN) cells into CD4+CD8+ double positive (DP)
cells and ﬁnally into single positive (SP) CD4+ or CD8+ cells. The DN cells can be further categorized into DN1, DN2, DN3 and DN4 cells.
ISP: immature single positive.
CD8+ cells which exit the thymus and enter the periphery
(Figure 2). The DN cells are further categorized accord-
ing to their CD44 and CD25 cell surface expression: (1)
DN1 (CD44+CD25−), (2) DN2 (CD44+CD25+), (3) DN3
(CD44−CD25+), and (4) DN4 (CD44−CD25−). Further-
more, the DN4 cells pass through a CD4
−CD8+ immature
single positive (ISP) stage before developing into DP cells.
The diﬀerent maturation stages are phenotypically and
functionally distinct.
The expression of GIMAP genes is strictly regulated
during T-cell development in the thymus. Dion et al. [13]
studied the expression of rat Gimaps in diﬀerent thymic
subpopulations and observed a signiﬁcant elevation in
expression of all rat Gimaps but Gimap 4 genes between
the DN and DP stages. The expression patterns for Gimap1,
6, 8, and 9 during thymocyte development were very
similar showing the highest expression in the DP stage.
Mouse Gimap 3, 4, 5, and 7 expression was increased
during the transition from CD4+CD8+ DP thymocytes
into CD4+ or CD8+ SP thymocytes [12]. While shRNA
mediated knockdown of mouse GIMAP4 hade no eﬀect
on thymocyte development in fetal thymic organ culture
model shRNA mediated knockdown of mouse GIMAP3 and
GIMAP5 disturbed thymocyte development [12]. Nitta et al.
[12] showed that GIMAP3 was needed for optimal positive
selection of SP CD4+ and CD8+ T-cells and Gimap5 was
important for optimal development of DP thymocytes. It
has also been shown that the proportion of CD4
−CD8+ SP
thymocytes was somewhat reduced in Gimap5 −/− mice [38].
Expression of mouse GIMAP4 protein during thymocyte
development has been studied in more detail by Poirier
et al. [1] and Schnell et al. [14]. It was not detectable in
DN1, DN2, DN3, or DP thymocytes whereas high levels of
GIMAP4 were expressed in SP CD4+ cells and DN4 cells
[1, 14]. The development of thymocytes in Rag−/− mice
is blocked at the DN3 stage but in vivo administration
of anti-CD3 antibody allows a low number of thymocytes
to proceed up to the DP-stage. This system allows for
the enrichment of the low-frequency cell subsets from the
diﬀerent developmental stages, namely, DN3, DN4, and ISP,
as well as DP cells. Using the Rag2−/− model, Schnell et
al. [14] demonstrated that mouse Gimap4 transcript was
absent in diﬀerentiation arrested Rag2−/− DN3 thymocytes
while it was present in high amounts in DN4, in lower
amounts in ISP, and absent in DP cell subsets of anti-
CD3 treated Rag2−/− mice. Similar results were obtained by
Poirier et al. [1]w i t haR a g −/− fetal thymic organ culture
(FTOC) model where thymocytes from Rag−/− mice blocked
at the DN3 stage were cultured in vitro with anti-CD3
antibodies. The antibody treatment resulted in the transient
expression of GIMAP4 protein between the DN3 and DP
developmental stages. The transitions both from DN3 to
DN4 stages and from DP to SP stages require TCR-mediated
signals, and, thus, the results described above indicate that
GIMAP4 expression is directly or indirectly induced by TCR-
mediated signals during thymocyte development. GIMAP4
was also shown to be upregulated by IL-7 signaling in mouse
DN thymocytes [39]. However, GIMAP4−/− mice showed
no signiﬁcant role for GIMAP4 in T-cell development in
thymus [14]. Thus, GIMAP4 seems to be dispensable for T-
cell development, although its expression is tightly regulated
during the development process.Journal of Signal Transduction 5
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Figure 3: Apoptosis. Apoptosis can be initiated by the extrinsic or intrinsic pathways. The extrinsic pathway involves binding of ligands,
suchastumornecrosisfactor(TNF)orFasligand(FasL)tothedeathreceptor.Subsequently,FAS-associatingdeathdomain(FADD)adapter
protein is recruited to the receptor which leads to activation of caspase-8. The intrinsic pathway is initiated by cellular stress which induces
loss of mitochondrial membrane potential, release of cytochrome C, and activation of caspase-9. The mitochondrial apoptotic pathway is
controlledbytheproapoptoticandantiapoptoticmembersoftheBcl-2family.CytochromeCreleaseisinhibitedbytheprosurvivalmembers
Bcl-2/Bcl-xL and promoted by proapoptotic BAX/BIM. Both extrinsic and intrinsic pathways lead to activation of caspase-3 and, ultimately,
cell death by apoptosis [40].
4.2. GIMAPs in Peripheral T-cell Functions. Studies have
indicated several roles for GIMAP proteins in peripheral T-
lymphocyte functions. GIMAPs have been studied in most
detail in apoptotic functions and in T-helper (Th) cell
diﬀerentiation and these processes are depicted in Figures 3
and 4 and discussed below.
4.3.GIMAP1. Mouse Gimap1wasﬁrstidentiﬁedbyKr¨ ucken
et al. [7] as a gene expressed in the spleens of mice infected
with Plasmodium chabaudi malaria. C57BL/10 mice are
capable of self-healing the P. chabaudi malaria infection and
this immunity is suppressed by testosterone. In the absence
of testosterone the immunity progresses to a long-lasting
protective immunity upon rechallenge. Once acquired, the
immunity is testosterone independent and mediated by
spleencells[41].ThehighexpressionofGimap1inthespleen
cells of P. chabaudi infected mice was strongly associated
with the acquisition of the testosterone-resistant, immunity-
mediating phenotype and was observed to be highest in
macrophages with lower expression in B cells and T-cells
[7]. Later it was shown that the expression of Gimap1 in
the spleens of the immune mice remains constitutively high
for at least 13 weeks postinfection [8]. Surprisingly, however,
a later study detected no upregulation of mouse GIMAP1
mRNA or protein in spleen cell lysates from mice infected
with P. chabaudi [9] and this phenomenon could not be
explained. Mouse Gimap1 has also been reported to be
upregulated by p53 during apoptosis in a mouse myeloid
leukemia cell line LTR6 [10]. A conditional knockout of
Gimap1 in murine lymphocytes led to severe reduction of
mature T and B cells but there was little eﬀect on immature
thymocytes [42]. Thus, GIMAP1 is critical for peripheral
lymphocyte survival.
Both human and mouse GIMAP1 orthologs are pref-
erentially expressed in the spleen with some expression in
the lymph nodes [6]. More detailed analysis of GIMAP1
protein expression in mouse splenic, thymic, and bone
marrow cell populations revealed GIMAP1 expression in6 Journal of Signal Transduction
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Figure 4: T-helper cell diﬀerentiation. Na¨ ıve Thp cells are able to diﬀerentiate into functional eﬀector cell subsets according to the cytokine
milieu. The diﬀerentiation process is initiated by antigen encounter. Naturally occurring regulatory T-cells are produced in the thymus. The
diﬀe r e n tr o l e so ft h ee ﬀector cells in the periphery are indicated in the ﬁgure.
T (CD3+) and B (B220+) cells, DN, DP, and CD4+ and
CD8+ SP thymocytes, as well as in NK/NKT (NK1.1+) cells
[9]. Interestingly, GIMAP1 was expressed at signiﬁcant levels
in 5 out of 11 tested lymphoid cancer cell lines, namely
C1498, TK-1, A20 and P815 [9].
It was shown that GIMAP1 was diﬀerentially expressed
during human Th1/Th2 diﬀerentiation [36]. Its expression
was induced by Th1 promoting cytokine IL-12 whereas
its expression was downregulated by IL-4, a Th2-inducing
cytokine. Promoter analysis of human GIMAP1 gene
revealed the existence of multiple silencer elements in the
promoter [6]. Stamm et al. [6] studied a large 6.2kb
fragment containing also the ﬁrst intron (from −3760 to
+2419). Deletion of sequences from the ﬁrst intron and from
the 5  ﬂanking area resulted in inducible promoter activity
indicating the removal of silencers. The smallest promoter
clone of 0.8kb (from −760 to +76) was highly active in
Jurkat cells thus suggesting that it contained all the elements
necessary for active transcription.
4.4. GIMAP3. GIMAP3-ps is a pseudogene in humans [3]
and Gimap3 is not annotated in the rat genome. Mouse
Gimap3 gene expression was detected at low levels in spleen,
but no expression was detected in thymus, liver, or kidney
[11]. However, high expression was detected in cell lines
expressing BCR/ABL. BCR/ABL is a chimeric oncogenic
protein generated from translocation between chromosomes
9and22resultingintheso-calledPhiladelphiachromosome.
BCR/ABL has constitutive tyrosine kinase activity and has
been shown to activate several signal transduction pathways,
such as RAS, RAF, MYC, and STAT [11]. Mouse GIMAP3
was also shown to bind GTP and localize in mitochondrial
membranes [11].
4.5. GIMAP4. GIMAP4 protein expression is highly regu-
lated at the post-transcriptional level [14, 15]. During T-
and B-cell activation by anti-CD3/anti-CD28 and CD40-
ligand/IL-4stimulation,respectively,themRNAlevelexpres-
sion of GIMAP4 was shown to be quite stable [15].
However, GIMAP4 protein level started to decrease after
4 days of T-cell activation and was undetectable at day
6. Similarly, yet more rapidly, B-cell activation resulted in
the reduction of GIMAP4 protein already after two days
of activation. The rapid activation induced phosphory-
lation/dephosphorylation/degradation of mouse GIMAP4
observed by Schnell et al. [14] also suggest a tight post-
transcriptional regulation.
The expression of rat GIMAP4 protein was approxi-
mately 10-fold greater in wild type lymph node (LN) T-cells
compared to LN T-cells from lyp/lyp (Gimap5 −/−)r a t[ 13].
It is not known whether this is due to GIMAP4 and GIMAP5
interactioninsomesharedbiochemicalpathwayoraresultofJournal of Signal Transduction 7
the altered activation status of T-cells from lyp/lyp animals.
The latter seems plausible in the light of the ﬁndings by
Cambot et al. [15] and Schnell et al. [14] indicating that both
human and mouse GIMAP4 protein expression decreased in
response to activation. While the majority of the peripheral
T-cells of wt animals are resting G0 cells, the T-cells in lyp/lyp
rats are a mixture of semiactivated cells and recent thymic
emigrants (RTE) [43, 44].
Although Gimap4 knockout seemed to be redundant
for T-cell development as well as selection and activation
of T-cells in vivo, the knockout had a signiﬁcant eﬀect
on T-cell apoptosis [14]. Apoptosis induces alterations in
the plasma membrane composition and permeabilisation. A
convenient method for measuring apoptosis is the staining
of exposed phosphatidylserine (PS) on plasma membrane
with ﬂuorochrome labeled Annexin V and measuring the
accumulation of propidium iodide (PI) in the nucleus after
alterations in plasma membrane permeability. Apoptotic
cells are, thus, PS positive and PI negative. When mature
splenic T-cells from wild-type and Gimap4−/− mice were
induced to apoptosis, the number of apoptotic (PS+/PI−)
cells was greater among the Gimap4−/− T-cells than the
wt T-cells and the number of dead cells were reduced
accordingly, that is, the cells executed apoptosis with slower
kinetics [14]. Furthermore, the accumulation of apoptotic
cells could be inhibited by caspase inhibitors, and there were
no changes in caspase-3 activation between apoptotic ko and
wt T-cells. This indicated that GIMAP4 acts downstream
of caspase-3 and plays a role rather in the execution
than the induction phase of apoptosis. A similar, but less
marked eﬀect was found in T-cells of the inbred Brown
Norway (BN) rat, which carries a natural hypomorphic
variant of the Gimap4 gene [16]. Further support for the
proapoptotic function of GIMAP4 came also from the
ﬁndings of Nitta et al. [12], who showed that ectopic
expression of GIMAP4 in immature mouse thymocytes
led to increased apoptosis. Furthermore, GIMAP4 protein
was shown to associate with the proapoptotic Bcl-2 family
protein Bax but not other Bcl-2 family members [12,
45].
Although Schnell et al. [14]a n dC a r t e re ta l .[ 16]
showed that GIMAP4 is largely a cytosolic protein Fil´ en et
al. [36] found it to be expressed in the membrane fraction
of human CD4+ T-helper cells. GIMAP4 expression was
furthermore shown to be tightly regulated during early
human CD4+ T-helper cell diﬀerentiation towards Th1 and
Th2 [36]. Proteomic analysis of IL-4 regulated membrane
proteins revealed downregulation of GIMAP4 during early
Th2 diﬀerentiation and it was further shown that IL-12
upregulated GIMAP4 expression during Th1 diﬀerentiation.
The diﬀerential expression of GIMAP4 was detected also
on mRNA level. The expression of two distinct isoforms of
GIMAP4 in response to IL-12 and IL-4 was also studied and
it was shown that they followed a similar expression pattern
in response to the studied cytokines, although the short
isoform was more highly abundant. RNAi studies further
showed that GIMAP4 protein expression was negatively
regulated by STAT6 in response to IL-4R signaling during
Th2 diﬀerentiation [36].
4.6. GIMAP5. Human GIMAP5 mRNA expression showed
very wide tissue distribution among most human tissues
outside the central nervous system [17, 18]. Its expression
was upregulated during human peripheral T-cell activation
[19]. It seemed to localize to the mitochondrial membrane
[18] although localization to the centrosome/ER/plasma
membrane [19] or to a distinct sedimentable subcellular
fraction outside ER and mitochondria [46] has also been
detected.TheregulationofGIMAP5geneexpressionremains
largely unknown but it has been shown that GIMAP5 is a
transcriptional target of Notch signaling in Jurkat cells [47].
An extensively studied genetic defect of lymphopenia
(i.e., lyp, also called Iddm2) in diabetes-prone BioBreeding
rat (BBDP)wasshown to be causedbya frameshift mutation
in the Gimap5 gene [20–23]. This frameshift deletion of
1bp introduces a premature STOP codon leading to a
truncated protein product. This deletion was absent in
the diabetes resistant BB (BBDR) rat [20, 21]. The BBDP
spontaneously develop insulin-dependent diabetes mellitus
(IDDM). It closely resembles human type 1 diabetes and is a
consequence of Th1-mediated destruction of pancreatic islet
β cells characterized by high levels of IFN-γ and IL-12 [48,
49]. The BBDP rat has severe, life-long T-cell lymphopenia
[43, 50] caused by increased apoptosis and shortened life-
span of recent thymic emigrants and peripheral T-cells [51–
53].However,theRTEcanberescuedfromapoptosisbyacti-
vation through TCR [51]. Furthermore, peripheral lyp/lyp
T-cells display normal Ca2+ signaling and proliferation in
response to TCR crosslinking [52]. Interestingly, the in vitro
life-span of lyp/lyp B cells is not aﬀected by the mutation
[52].
The lymphopenic phenotype of the BBDP rat argues
for anti-apoptotic function for GIMAP5. The studies with
the mutated GIMAP5 in BBDP rat by Pandarpurkar et
al. [24], Keita et al. [46], and Pino et al. [54]a n dw i t h
human GIMAP5 by Sandal et al. [17] support this ﬁnding.
Mitochondrial membrane potential was found to be lower in
BBDP T-cells than in BBDR T-cells. The lack of full-length
GIMAP5 in BBDP rat T-cells lead to ER stress signaling and
C/EBP homologous protein-(CHOP)-mediated apoptosis
[54]. Thus, GIMAP5 is a regulator of ER homeostasis in
rat T-cells. The BBDP rat T-cells also display an impaired
TCR-stimulated Ca2+ response which suggests that GIMAP5
is a regulator of calcium responses in T-lymphocytes [55].
Moreover, knockdown of Gimap5 by RNAi in Jurkat T-
cells resulted in increased apoptosis [24]. Gimap5 −/− mice
exhibit peripheral T-cell lymphopenia, especially of CD8+
T-cells [38]. The Gimap5 −/−CD8+ splenocytes furthermore
showed increased apoptosis [38]. Overexpression of human
GIMAP5 in Jurkat T-cell line resulted in increased resistance
to okadaic acid or γ-irradiation induced apoptosis. The anti-
apoptotic function of GIMAP5 was shown to be upstream of
caspase-3 [17]. However, more recent studies by Dalberg et
al.[19]werecontradictorytotheearlierﬁndingsandshowed
a proapoptotic function for human GIMAP5. They showed
thatGIMAP5knockdownbyRNAididnotaﬀectthenumber
of apoptotic cells but overexpression of GIMAP5 in both
Jurkat T-cells and na¨ ıve T-cells led to increased apoptosis
[19]. Furthermore, they showed that while expression of the8 Journal of Signal Transduction
wt rat GIMAP5 led to increased apoptosis of the cells, the
expression of the truncated GIMAP5-LYP in C58, a rat T-
cell line, led to a very rapid death of the transfected cells
[19]. This indicated a function for the truncated GIMAP5-
LYP. Albeit the results obtained by diﬀerent research groups
seem contradictory, they may only indicate that the role of
GIMAP5 in apoptosis is dependent on the activation status
of the cells and the availability of growth factors.
When the rat Gimap5-Lyp mutation was backcrossed
into PVG-RT1u rat strain the lyp/lyp rats developed
a spontaneous, progressive, inﬂammatory bowel disease
with Th2 characteristics [56]. Indeed, the puriﬁed lyp/lyp
CD4+CD45RClo cells produced increased amounts of IL-
4 but similar amounts of IFN-γ compared to control wt
cells. Also the expression of IL-4 and IL-13 was higher
in the lyp/lyp c e l l sc o m p a r e dt ow t[ 56]. Accordingly,
chemical mutation of mouse Gimap5 led to severe intestinal
inﬂammation and wasting disease [57].
A common polyadenylation polymorphism in the
human GIMAP5 gene was associated with the risk to
autoimmune systemic lupus erythematosus (SLE) [58]a n d
with the increased prevalence of IA-2 autoantibodies in
patients with type I diabetes [59]. This polymorphism
produces an ineﬃcient polyadenylation signal to the 3  part
of the GIMAP5 mRNA and leads to increased proportion of
nonterminated mRNA [58].
5. Concluding Remarks
There are a growing number of reports describing a func-
tional role for GIMAP family proteins in lymphocyte biology
and we have discussed the role of GIMAPs in T-lymphocyte
functions. More investigation is warranted to reveal the
detailed molecular mechanism of GIMAP protein function.
Determining, for example, the interaction partners, site of
action, and signaling pathways will strengthen our knowl-
edge of the function of this highly interesting novel family
of GTPases.
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